|
| |
| Cat. No |
Model |
Description |
Unit |
Price
(VAT별도) |
납기 |
재고 |
DataSheet |
주문/견적 |
| LCA-25-386097 |
GTX15138 |
Acrolein antibody//Human,Rabbit/Rabbit |
1/EA |
|
|
|
 |
문의 |
|
|
|
|
|
|
|
Subject
|
Acrolein antibody |
|
Description
|
/ Human,Rabbit/Rabbit |
|
Clonality
|
Poly |
|
Company
|
GeneTex |
|
Application
|
ELISA |
|
Conjugation
|
|
|
Immunogen
|
|
|
Contents
|
| Catalog Number | GTX15138 | | Product Name | Acrolein antibody | | Product Description | Rabbit polyclonal to Acrolein | | Background | Acrolein, a reactive alpha,beta-unsaturated aldehyde, is a common environmental pollutant, a metabolite of the anticancer drug cyclophosphamide, and a byproduct of lipid peroxidation. An increase in acrolein production has been proposed as a marker for Alzheimers disease, diabetic glomerular lesions, and atherosclerosis. Acrolein is a potent inhibitor of cell proliferation at nonlethal doses and may act through effects on redox-regulated transcription factors. It has been reported that NF-kappaB activation is inhibited by acrolein. | | Clonality | Polyclonal | | Host | Rabbit | | Isotype | IgG | | Immunogen | Acrolein carriers. | | Tested Applications | ELISA. The usefulness of this product in other applications has not been determined. | | Application Note | ELISA: Use at a dilution of 1/2000 - 1/5000. Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user. | | Specificity | Using a conjugate Acrolein Protein, antibody specificity was performed with an ELISA test by competition experiments with the following compounds.Acrolein-BSA (ratio 1:1), Malondialdehyde-BSA (1:55), Glyoxal-BSA (1:> 50,000), Formaldehyde-BSA (1:> 50,000), Glutaraldehyde-BSA (1/> 50,000). Crossreactivity ratio is the Acrolein BSA concentration/unconjugated or conjugated analogs concentration at half displacement. | | Target | Acrolein | | Purification | Immunogen affinity purified | | Storage Buffer | Preservative: NoneConstituents: 40% Glycerol, PBS | | Notes | For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer." | |
|
|
|
|
